Journal List > J Korean Ophthalmol Soc > v.57(9) > 1010387

Kang and Kim: Clinical Outcomes of Combined Descemet-stripping Endothelial Keratoplasty and Intraocular Lens Exchange

Abstract

Purpose

To evaluate clinical outcomes after combined descemet-stripping endothelial keratoplasty (DSEK) and intraocular lens (IOL) exchange in a Korean population.

Methods

The medical records of 15 patients (15 eyes) with pseudophakic bullous keratopathy who underwent combined DSEK and IOL exchange from January 2011 to January 2015 and who were followed up for more than 12 months were reviewed retrospectively.

Results

In 14 eyes with successful results after surgery, the best corrective visual acuity (BCVA) was significantly improved from 2.01 ± 0.96 (log MAR, mean) to 0.68 ± 0.26 at 3 months (p = 0.001) except for one eye that received reoperation on the endothelial disc detachment. The BCVA at postoperative 6 and 12 months gradually increased (0.51 ± 0.26 and 0.40 ± 0.22 log MAR, mean). Central corneal thickness was significantly improved from 777 ± 139 μ m to 605 ± 28 μ m at 6 months (p = 0.003) and was maintained at 12 months. The mean endothelial cell count was 2,973 ± 281/mm2 in the donor lenticules and 1,790 ± 265/mm2 at 12 months. Endothelial cell loss was 40%. The target refraction was −0.81 ± 0.16 D and the 12 months postoperative spherical equivalent was −0.28 ± 0.36 D. Complications included intraocular pressure elevation in one eye and pupillary capture in one eye.

Conclusions

Combined DSEK and IOL exchange may be a very efficient and safe option for surgically managing pseudophakic bullous keratopathy.

References

1. Gorovoy MS, Price FW. New technique transforms corneal transplantation. Cataract Refract Surg Today. 2005; 11:55–8.
2. Koenig SB, Covert DJ, Dupps WJ Jr, Meisler DM. Visual acuity, refractive error, and endothelial cell density six months after Descemet stripping and automated endothelial keratoplasty (DSAEK). Cornea. 2007; 26:670–4.
crossref
3. Terry MA. Endothelial keratoplasty: history, current state, and future directions. Cornea. 2006; 25:873–8.
4. Shimazaki J, Amano S, Uno T, et al. National survey on bullous keratopathy in Japan. Cornea. 2007; 26:274–8.
crossref
5. Gonçalves ED, Campos M, Paris F, et al. Bullous keratopathy: etio-pathogenesis and treatment. Arq Bras Oftalmol. 2008; 71(6 Suppl):61–4.
6. Balázs E, Balázs K, Módis L Jr, Berta A. Penetrating keratoplasty for pseudophakic bullous keratopathy. Acta Chir Hung. 1997; 36:11–3.
7. Barkana Y, Segal O, Krakovski D, et al. Prediction of visual abdominal after penetrating keratoplasty for pseudophakic corneal edema. Ophthalmology. 2003; 110:286–90.
8. Wylegala E, Tarnawska D. Management of pseudophakic bullous keratopathy by combined Descemet-stripping endothelial abdominal and intraocular lens exchange. J Cataract Refract Surg. 2008; 34:1708–14.
9. Chan CC, Crandall AS, Ahmed II. Ab externo scleral suture loop fixation for posterior chamber intraocular lens decentration: abdominal results. J Cataract Refract Surg. 2006; 32:121–8.
10. Djalilian AR, Anderson SO, Fang-Yen M, et al. abdominal results of transsclerally sutured posterior chamber lenses in penetrating keratoplasty. Cornea. 1998; 17:359–64.
11. Chen ES, Shamie N, Terry MA. Descemet-stripping endothelial keratoplasty: improvement in vision following replacement of a healthy endothelial graft. J Cataract Refract Surg. 2006; 34:1044–6.
crossref
12. Price MO, Price FW Jr. Descemet's stripping with endothelial keratoplasty: comparative outcomes with microkeratome-dissected and manually dissected donor tissue. Ophthalmology. 2006; 113:1936–42.
13. Covert DJ, Koenig SB. New triple procedure: Descemet's stripping and automated endothelial keratoplasty combined with abdominal and intraocular lens implantation. Ophthalmology. 2007; 114:1272–7.
14. Holz HA, Meyer JJ, Espandar L, et al. Corneal profile analysis abdominal Descemet stripping endothelial keratoplasty and its relationship to postoperative hyperopic shift. J Cataract Refract Surg. 2008; 34:211–4.
15. Suto C, Hori S, Fukuyama E, Akura J. Adjusting intraocular lens power for sulcus fixation. J Cataract Refract Surg. 2003; 29:1913–7.
crossref
16. Allan BD, Terry MA, Price FW Jr, et al. Corneal transplant abdominal rate and severity after endothelial keratoplasty. Cornea. 2007; 26:1039–42.
17. Gorovoy MS. Descemet-stripping automated endothelial keratoplasty. Cornea. 2006; 25:886–9.
crossref
18. Lee K, Hwang KY, Kim MS. Influence of endothelial cell loss abdominal preservation on graft survival in imported donor cornea. J Korean Ophthalmol Soc. 2013; 54:862–8.
19. Ide T, Yoo SH, Goldman JM, et al. Descemet-stripping automated endothelial keratoplasty: effect of inserting forceps on DSAEK abdominal tissue viability by using an in vitro delivery model and vital dye assay. Cornea. 2007; 26:1079–81.
20. Michaeli A, Assia EI. Scleral and iris fixation of posterior chamber lenses in the absence of capsular support. Curr Opin Ophthalmol. 2005; 16:57–60.
crossref
21. van der Schaft TL, van Rij G, Renardel de Lavalette JG, Beekhuis WH. Results of penetrating keratoplasty for pseudophakic bullous keratopathy with the exchange of an intraocular lens. Br J Ophthalmol. 1989; 73:704–8.
crossref

Figure 1.
Changes in best corrected visual acuity (BCVA) after combined descemet-stripping endothelial keratoplasty and intraocular lens exchange. The BCVA improved at post-operative 3 months. * Wilcoxon signed rank test.
jkos-57-1361f1.tif
Figure 2.
Changes in central corneal thickness (CCT) after combined descemet-stripping endothelial keratoplasty and intraocular lens exchange. * Wilcoxon signed rank test.
jkos-57-1361f2.tif
Figure 3.
Changes in endothelial cell count (ECC) after combined descemet-stripping endothelial keratoplasty and intraocular lens exchange. * Wilcoxon signed rank test.
jkos-57-1361f3.tif
Table 1.
Characteristics of the patient who underwent combined descemet-stripping endothelial keratoplasty and intraocular lens (IOL) exchange
Case Age (years) Sex Diagnosis Associated ocular morbidity Cormorbidity Postop complication Remark
1 65 F IOL dislocation HTN IOP elevation
2 55 M IOL dislocation Pupillary capture
3 74 M ACL Prev. RRD, Vit. eye HTN
4 71 M IOL dislocation Prev. uveitis DM, HTN
5 83 F ACL Glaucoma Hyperthyroidism
6 71 F IOL dislocation
7 61 M IOL dislocation ERM, CME
8 83 M IOL dislocation Optic atrophy
9 64 M ACL Glaucoma DM, HTN
10 71 M ACL CSC HTN
11 42 M IOL dislocation DM, HTN
12 67 M ACL
13 77 M IOL dislocation CME
14 50 M IOL dislocation
15 50 M ACL Prev. RRD, Vit. eye Vitreous hemorrhage PKP after total Endothelial disc detachment

HTN = hypertension; IOP = intraocular pressure; ACL = anterior chamber lens; Prev. = previous; RRD = rhegmatogenous retinal detachment; Vit. eye = vitrectomized eye; DM = diabetes melitus; ERM = epiretinal membrane; CME = cystoid macular edema; CSC = chronic central serous chorioretinopathy; PKP = penetrating keratoplasty.

Table 2.
Pre- and postoperative best corrected visual acuity (BCVA, log MAR), keratometry and refractive error (D) at 12 months after operation
Case Preop BCVA Postop BCVA
Preop Mean K (D) Postop Mean K (D) Target power (D) Refractive error (D)
S/E (D)
3 months 6 months 12 months Spherical Cylinder
1 1.7 0.7 0.4 0.3 44.5 44.5 −0.79 +0.25 −1.0 −0.25
2 0.7 0.2 0.2 0.1 42.625 42.75 −0.85 +0.5 −1.25 −0.125
3 1.7 1.0 1.0 0.7 42.375 42.5 −0.94 +0.5 −1.5 −0.25
4 0.7 0.3 0.2 0.1 43.5 43.5 −0.87 +0.5 −1.75 −0.375
5 0.7 0.4 0.3 0.3 42.625 42.5 −0.82 −0.5 −0.5 −0.75
6 1.3 1.0 1.0 0.7 42.625 42.75 −1.22 0 −1.0 −0.5
7 3.0 1.0 0.7 0.7 43.25 43.25 −0.7 +0.5 −2.0 −0.5
8 3.0 1.0 0.7 0.7 43 43.25 −0.95 0 −1.0 −0.5
9 3 0.7 0.5 0.5 44.5 44.5 −0.58 +0.5 −1.5 −0.25
10 3 0.7 0.5 0.4 45.875 46 −0.63 +0.75 −1.25 0.125
11 3 0.7 0.5 0.3 44.875 45 −0.81 +1.0 −1.0 0.5
12 1.7 0.7 0.5 0.4 43.25 43.5 −0.71 +0.25 −2.0 −0.75
13 1.7 0.5 0.3 0.2 48.375 48 −0.64 +0.5 −0.5 0.25
14 3 0.7 0.4 0.3 45.75 46 −0.82 0 −1.0 −0.5
Mean 2.01 ± 0.96 0.68 ± 0.26 0.51 ± 0.26 0.40 ± 0.22 44.08 ± 1.70 44.21 ± 1.82 −0.81 ± 0.16 0.33 ± 0.37 −1.23 ± 0.47 −0.28 ± 0.36
p-value 0.001* 0.001* 0.001* 0.143 0.001*

Values are presented as mean ± SD unless otherwise indicated.

D = diopter; K = keratometry; Preop = preoperative; Postop = postoperative; S/E = spherical equivalent.

* Show statically significant difference compared to preoperative value (p < 0.05, Wilcoxon signed ranks test).

Table 3.
Pre- and postoperative central corneal thickness (CCT), donor and postoperative endothelial cell count
Case Preop CCT (μ m) Postop CCT (μ m)
Donor ECC Postop ECC
6 months 12 months 6 months 12 months
1 678 N/D 587 2,631 N/D 1,686
2 654 N/D 585 3,150 2,405 2,324
3 724 N/D 607 3,297 N/D 1,443
4 705 582 594 2,278 1,542 1,499
5 1,184 542 521 3,003 N/D 2,141
6 799 621 615 3,040 1,675 1,536
7 654 633 608 3,055 1,854 1,774
8 752 624 595 3,352 1,799 1,693
9 907 589 578 2,950 N/D 2,119
10 842 612 588 3,254 2,004 1,992
11 707 593 598 2,842 1,671 1,585
12 684 632 604 2,975 1,974 1,832
13 798 634 623 2,777 N/D 1,624
14 785 594 575 3,024 1,876 1,813
Mean 777 ± 139 605 ± 28 591 ± 24 2,973 ± 281 1,866 ± 251 1,790 ± 265
p-value 0.003* 0.001* 0.008* 0.001*

Values are presented as mean ± SD unless otherwise indicated.

Preop = preoperative; Postop = postoperative; ECC = endothelial cell count; N/D = not done.

* Show statically significant difference compared to preoperative value (p < 0.05, Wilcoxon signed ranks test).

TOOLS
Similar articles